As Thailand overrides patents on foreign drugs, the only winner will be the government.

Requirements to test new drugs against older medicines would add a major hurdle to the development and approval of new medicines. Equally important, the proposed mandates are unnecessary.

Help for medicinal innovation in Thailand is coming from an unlikely source.

Thailand's government is breaking Western pharmaceutical patents--not for health reasons, but for its own financial gain.

The Thai government is breaking patents on Western drugs, but such actionwill haveconsequences for theThailand,afflicted patients, and global health.

Reports from AARP and Families USA have heightened concerns among policymakers and the public about the affordability of prescription drugs. However, those reports are misleading.

Differential pricing is necessary to provide suffering people in poor countries access to needed medicines and ensure that medical innovation will continue in the future.